ARTICLE | Company News
Vectura, Boehringer Ingelheim deal
January 25, 2016 8:00 AM UTC
Vectura disclosed that its partner for a 2011 deal to develop and commercialize VR315 is Boehringer’s Roxane Laboratories Inc. subsidiary. Vectura has received $12 million in milestone payments under...